Under construction – not a live service
Sign in
Not yet recruitingNo phase

Artificial Intelligence (AI)-Assisted Sleep Intervention for Insomnia in Older Adults With Subjective Cognitive Decline

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
The Hong Kong Polytechnic University
Trial code
NCT07588035
Record updated
14 May 2026
Original description
To assess the feasibility and acceptability of Artificial Intelligence (AI)-assisted sleep intervention on improving the insomnia of older adults with subjective cognitive decline.Read full original descriptionShow less

Artificial Intelligence (AI)-Assist Sleep Intervention for Insomnia Among Older Adults With Subjective Cognitive Decline: A Pilot Randomized Controlled Trial

To assess the feasibility and acceptability of Artificial Intelligence (AI)-assisted sleep intervention on improving the insomnia of older adults with subjective cognitive decline.

Inclusion: older adults aged ≥ 60 years; Subjective cognitive decline questionnaire 9 (SCD-Q9) ≥ 5; Montreal Cognitive Assessment (MoCA) ≥ 26. If the number of years of education is less than 12, one point will be added to the total score; with insomnia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and Insomnia Severity Index (ISI) ≥ 8; reachable by phone.

Exclusion: having a previously diagnosed primary sleep disorder, such as sleep apnoea; suffering from a severe chronic illness that could contribute to sleep problems (e.g., emphysema); currently undergoing medical, psychological, or psychiatric treatment for sleep disturbances or depression; having significant visual or hearing impairments.

ClinicalTrials.gov NCT07588035